Trial Holdings Inc. AI Stock Analysis
Want to see JP:141A full AI Analyst Report?
Trial Holdings Inc. (141A) AI Stock Analysis
Trial Holdings Inc.
(TSE/TYO:141A)
The overall score reflects strong top‑line growth and solid operating scale offset by compressed net margins, high leverage and uneven cash conversion, making financial risk the dominant consideration. Technicals are supportive with a pronounced uptrend, but overbought signals temper the outlook and suggest more volatility around current levels. A rich valuation with a high P/E and minimal yield further limits upside, as the market already prices in substantial execution success.
Trial Holdings Inc. (141A) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 507.71B
- Dividend Yield
- 0.41%
- Average Volume (3M)
- 699.24K
- Price to Earnings (P/E)
- 143.3
- Beta (1Y)
- 0.36
- Revenue Growth
- 48.11%
- EPS Growth
- 13.12%
- Country
- Japan
- Employees
- 9,434
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Discount Stores
Trial Holdings Inc. Business Overview & Revenue Model
Company Description
Trial Holdings Inc. is a diversified enterprise actively engaged across several key sectors, including retail commerce, supply chain management, financial technology services, and specialized retail technology solutions. The company manages an extens...
Trial Holdings Inc. Financial Statement Overview
Summary
Financial performance is mixed: revenue growth is very strong and margins at the operating level are reasonable, but net margin has compressed sharply and leverage has risen materially, while cash generation is positive but volatile and only moderately supports reported earnings.
Income Statement
82Very PositiveBalance Sheet
41NeutralCash Flow
58Neutral| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.36T | 1.36T | 720.44B | 806.59B | 655.48B | 597.69B |
| Gross Profit | 337.38B | 337.38B | 134.00B | 155.13B | 117.53B | 103.49B |
| EBITDA | 71.27B | 69.13B | 30.78B | 33.73B | 25.03B | 21.58B |
| Net Income | 3.52B | 3.52B | 11.44B | 11.75B | 8.09B | 7.13B |
Balance Sheet | ||||||
| Total Assets | 807.82B | 807.82B | 283.63B | 300.28B | 200.64B | 185.73B |
| Cash, Cash Equivalents and Short-Term Investments | 68.90B | 68.90B | 91.95B | 72.33B | 23.90B | 27.43B |
| Total Debt | 394.63B | 394.63B | 16.16B | 38.56B | 19.61B | 24.44B |
| Total Liabilities | 673.45B | 673.45B | 165.44B | 171.25B | 132.62B | 126.02B |
| Stockholders Equity | 130.90B | 130.90B | 115.68B | 126.13B | 65.89B | 57.96B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 47.10B | 36.90B | -38.41B | 2.55B | 10.01B |
| Operating Cash Flow | 0 | 92.06B | 59.50B | -4.45B | 18.45B | 22.34B |
| Investing Cash Flow | 0 | -405.01B | -26.00B | -35.89B | -16.77B | -13.49B |
| Financing Cash Flow | 0 | 309.39B | 34.50B | 20.77B | -5.19B | -4.32B |
Trial Holdings Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:141A, the sentiment is Positive. The current price of 4120.00 is above the 20-day moving average (MA) of 3880.50, above the 50-day MA of 3867.60, and above the 200-day MA of 3617.04, indicating a bullish trend. The MACD of 126.55 indicates Negative momentum. The RSI at 56.89 is Neutral, neither overbought nor oversold. The STOCH value of 61.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:141A.
Trial Holdings Inc. Peers Comparison
Overall Rating
JP:997478Outperform
JP:819876.4Outperform
JP:753276Outperform
JP:824273Outperform
JP:819471Outperform- JP:141A63Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:9974 | 78Outperform | JPY 137.09B | 12.61 | ― | 1.90% | 4.94% | -9.98% |
| JP:8198 | 76Outperform | JPY 100.24B | 12.95 | ― | 2.67% | 0.90% | -28.84% |
| JP:7532 | 76Outperform | JPY 2.37T | 20.91 | 16.51% | 1.23% | 11.10% | 10.49% |
| JP:8242 | 73Outperform | JPY 336.31B | 8.57 | 12.34% | 1.69% | -0.44% | 172.74% |
| JP:8194 | 71Outperform | JPY 234.21B | 21.60 | ― | 2.51% | 2.59% | 0.10% |
| JP:141A | 63Neutral | JPY 519.72B | 143.25 | ― | 0.41% | 48.11% | 13.12% |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:141A | Trial Holdings Inc. | 4120.00 | 1718.09 | 71.53% | |
| JP:7532 | Pan Pacific International Holdings Corporation | 770.00 | -172.67 | -18.32% | |
| JP:8242 | H2O Retailing Corporation | 2838.50 | 712.13 | 33.49% | |
| JP:8194 | Life Corporation | 2705.00 | 268.06 | 11.00% | |
| JP:8198 | Maxvalu Tokai Co., Ltd. | 3185.00 | -226.62 | -6.64% | |
| JP:9974 | BELC Co., Ltd. | 6730.00 | -561.71 | -7.70% |
Trial Holdings Inc. Corporate Events
TRIAL Holdings Reports Quarterly Sales Growth and Profit
TRIAL Holdings reported consolidated net sales of ¥355,432 million for the three months ended September 30, 2026, up 8.8% year on year, while EBITDA rose 40.9% to ¥20,712 million. Operating profit increased 107.0% to ¥10,639 million and ordinary prof...
TRIAL Reports Consecutive Same-Store Sales Growth at TRIAL and SEIYU
TRIAL Holdings operates in distribution and retail, selling grocery, daily products, fresh food, ready meals, household essentials, hardware and apparel through TRIAL and SEIYU stores. The business serves customers through Super Center and smart form...
TRIAL Holdings Completes Seiyu Subsidiary Restructuring
TRIAL Holdings said an absorption-type company split involving its subsidiaries became effective on November 1, 2026, completing a restructuring linked to the partial liquidation of real estate held by Seiyu. Renamed Seiyu Co., Ltd. assumed the forme...
Trial Holdings Extends Same-Store Sales Rally as New Super Centers Open
Trial Holdings reported continued same-store sales growth across its TRIAL and SEIYU chains in the first half of fiscal 2027, driven by strong demand for fresh foods, ready meals and private-brand offerings despite unusually wet weather and cooler te...
TRIAL Holdings Details Majority Ownership and Minority Shareholder Safeguards
TRIAL Holdings, Inc. has disclosed that THC Corporation, an asset management company owned by President Hiro Nagata and his relatives, is its controlling shareholder with 53.76% of voting rights. The announcement clarifies that there are currently no...
Trial Holdings Books Internal Dividend and Loan Provisions With No Impact on Group Earnings
Trial Holdings, Inc. has recorded dividend income of 7,500 million yen from its consolidated subsidiary Trial Company, Inc. in its non-consolidated results for FY6/2026, while simultaneously booking a 5,461 million yen provision for doubtful accounts...
TRIAL Holdings Posts Sustained Sales Growth as Value Offerings Drive Traffic
TRIAL Holdings reported continued year-on-year sales growth across its TRIAL and SEIYU stores, underpinned by rising customer traffic and strong demand for fresh foods, ready meals and private-brand items despite varied weather conditions and disrupt...
TRIAL Holdings to Monetize Seiyu Real Estate and Restructure Subsidiaries to Cut Debt
TRIAL Holdings has approved a restructuring of its Seiyu sub-subsidiary to partially monetize Seiyu’s real estate, seeking to raise about ¥17 billion to relieve the sharp increase in interest-bearing debt that followed the 2025 Seiyu acquisition. The...
Trial Holdings Updates FY2026 Results and Issues FY2027 Forecast
Trial Holdings, Inc. has released materials outlining its financial results for the fiscal year ending June 30, 2026, covering the period from July 1, 2025, to June 30, 2026. The release also notes partial modifications to previously reported figures...
TRIAL Holdings Posts Surging Sales but Profit Drops as Balance Sheet Swells
TRIAL Holdings reported a sharp 67.6% jump in net sales to ¥1.35 trillion and a doubling of EBITDA for the fiscal year ended June 30, 2026, driven by business expansion, though operating margin remained modest and profit attributable to owners of par...
TRIAL Holdings Tops FY2026 Forecasts and Lifts Year-End Dividend
TRIAL Holdings reported full-year results for the fiscal year ended June 30, 2026 that modestly beat its May forecast on sales and more strongly on profits, helped by stronger-than-expected net sales and gross profit and lower extraordinary losses. N...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026